Completed OBSERVATIONAL NCT03899870

Factors Predicting Recurrence in Rectal Cancer After Surgery

Factors Predicting Recurrence After Curative Resection for Rectal Cancer: a 16-year Study

Sponsor: ammar houssem

Conditions Rectal Adenocarcinoma Rectal Cancer

Interventions Adjuvant therapy Neoadjuvant therapy Rectal resection

Updated 4 times since 2019 Last updated: Mar 30, 2019 Started: Jan 1, 2000 Primary completion: Dec 31, 2015 Completion: Jan 15, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03899870, this observational or N/A phase trial focuses on Rectal Adenocarcinoma and Rectal Cancer and remains completed. Sponsored by ammar houssem, it has been updated 4 times since 2000, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
May 2019 — Jan 2021 [monthly]

Completed

First recorded

Jan 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

ammar houssem

Data source: Université de Sousse

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.